Spectrum of clonal hematopoiesis in VEXAS syndrome (2023)
- Authors:
- Autor USP: RODRIGUES, RODRIGO DO TOCANTINS CALADO DE SALOMA - FMRP
- Unidade: FMRP
- DOI: 10.1182/blood.2022018774
- Subjects: HEMATOPOESE; DERMATITE; MUTAÇÃO; ESTUDOS PROSPECTIVOS; ESTUDOS RETROSPECTIVOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2023
- Source:
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
GUTIERREZ-RODRIGUES, Fernanda et al. Spectrum of clonal hematopoiesis in VEXAS syndrome. Blood, v. 142, n. 3, p. 244-259, 2023Tradução . . Disponível em: https://doi.org/10.1182/blood.2022018774. Acesso em: 28 dez. 2025. -
APA
Gutierrez-Rodrigues, F., Kusne, Y., Fernandez, J., Lasho, T. L., Shalhoub, R. N., Koster, M. J., et al. (2023). Spectrum of clonal hematopoiesis in VEXAS syndrome. Blood, 142( 3), 244-259. doi:10.1182/blood.2022018774 -
NLM
Gutierrez-Rodrigues F, Kusne Y, Fernandez J, Lasho TL, Shalhoub RN, Koster MJ, Begna K, Ombrello AK, Ferrada MA, Wilson L, Calado RT. Spectrum of clonal hematopoiesis in VEXAS syndrome [Internet]. Blood. 2023 ; 142( 3): 244-259.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1182/blood.2022018774 -
Vancouver
Gutierrez-Rodrigues F, Kusne Y, Fernandez J, Lasho TL, Shalhoub RN, Koster MJ, Begna K, Ombrello AK, Ferrada MA, Wilson L, Calado RT. Spectrum of clonal hematopoiesis in VEXAS syndrome [Internet]. Blood. 2023 ; 142( 3): 244-259.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1182/blood.2022018774 - Androgen treatment mitigates hematopoietic cell telomere attrition in vivo
- Age-adjusted recipient pretransplantation telomere length and treatment-related mortality after hematopoietic stem cell transplantation
- Telomeres in disease
- Células reprogramadas. [Depoimento a Hérika Dias e Luis Ribeiro]
- Telomere shortening in hepatocyte proliferation and predisposition to alcohol-induced steatosis
- Efficacy and safety of eltrombopag combined with cyclosporine as first-line therapy in adults with severe acquired aplastic anemia: results of the interventional phase 2 single-arm soar study
- A novel homozygous RTEL1 variant in a consanguineous Lebanese family: phenotypic heterogeneity and disease anticipation
- GATA2 mutation in long stand Mycobacterium kansasii infection, myelodysplasia and MonoMAC syndrome: a case-report
- Molecular characterization of clinical response and relapse in patients with IDH1m ND-AML treated with Ivo+AZA in the aGILE study
- BCL2A1a over-expression in murine hematopoietic stem and progenitor cells decreases apoptosis and results in hematopoietic transformation
Informações sobre o DOI: 10.1182/blood.2022018774 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003192999.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
